[Federal Register Volume 85, Number 174 (Tuesday, September 8, 2020)]
[Notices]
[Page 55466]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-19690]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Council on Blood Stem Cell 
Transplantation

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Secretary's Advisory Council on Blood Stem 
Cell Transplantation (ACBSCT) has scheduled a public meeting. 
Information about ACBSCT and the agenda for this meeting can be found 
on the ACBSCT website at https://bloodstemcell.hrsa.gov/about/advisory-council.

DATES: September 25, 2020, from 12:00 p.m.-6:00 p.m. Eastern Time (ET).

ADDRESSES: This meeting will be held by webinar and conference call. 
The webinar link, conference call-in number, registration information, 
and meeting materials can be accessed through the registration link on 
the ACBSCT website at https://bloodstemcell.hrsa.gov/about/advisory-council.

FOR FURTHER INFORMATION CONTACT: Robert Walsh, Designated Federal 
Official, (DFO), at Division of Transplantation, HRSA, 5600 Fishers 
Lane, Rockville, Maryland 20857; 301-443-6839; or [email protected].

SUPPLEMENTARY INFORMATION: ACBSCT provides advice and recommendations 
to the Secretary of HHS (Secretary) and the HRSA Administrator on the 
activities of the C.W. Bill Young Cell Transplantation Program 
(CWBYCTP) and the National Cord Blood Inventory (NCBI) Program. The 
principal purpose of these programs is to make blood stem cells from 
adult donors and cord blood units available for patients who need a 
transplant to treat life-threatening conditions such as leukemia, and 
who lack a suitably matched relative who can be the donor.
    During the September 25, 2020, meeting, the ACBSCT will receive 
updates on the operation of the CWBYCTP and the NCBI and discuss cord 
blood as a continued source of blood stem cells for transplant in the 
context of other available sources of blood stem cells for transplant. 
Agenda items are subject to change as priorities dictate. Refer to the 
ACBSCT website for any updated information concerning the meeting.
    Members of the public will have the opportunity to provide 
comments. Public participants may submit written statements in advance 
of the scheduled meeting. Oral comments will be honored in the order 
they are requested and may be limited as time allows. Requests to 
submit a written statement or make oral comments to ACBSCT should be 
sent to Robert Walsh, DFO, using the contact information above at least 
three business days prior to the meeting.
    Individuals who plan to attend and need special assistance or 
another reasonable accommodation should notify Robert Walsh at the 
address and phone number listed above at least 10 business days prior 
to the meeting.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020-19690 Filed 9-4-20; 8:45 am]
BILLING CODE 4165-15-P